Sjur Olsnes interviewed about the development in cancer research
An interesting interview with Professor Sjur Olsnes from the Department of Biochemistry has recently been published on the web pages of The Norwegian Cancer Society (in Norwegian). Here, he describes the development in cancer research the last 40 years.
Wiig JN, Dagenborg VJ, Larsen SG(2024) Ten-year survival and pattern of recurrence in patients with locally recurrent rectal or sigmoid cancer undergoing resection Colorectal Dis(in press) DOI 10.1111/codi.17226, PubMed 39635974
Chen L, Wang X, Xie N, Zhang Z, Xu X, Xue M, Yang Y, Liu L, Su L, Bjaanæs M, Karlsson A, Planck M, Staaf J, Helland Å, Esteller M, Christiani DC, Chen F, Zhang R(2024) A two-phase epigenome-wide four-way gene-smoking interaction study of overall survival for early-stage non-small cell lung cancer Mol Oncol(in press) DOI 10.1002/1878-0261.13766, PubMed 39630602
Katona BW, Lubinski J, Pal T, Huzarski T, Foulkes WD, Moller P, Eisen A, Randall Armel S, Neuhausen SL, Raj R, Aeilts A, Singer CF, Bordeleau L, Karlan B, Olopade O, Tung N, Zakalik D, Kotsopoulos J, Fruscio R, Eng C, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group(2024) The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation Cancer(in press) DOI 10.1002/cncr.35666, PubMed 39611336